Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials

Introduction Patients undergoing coronary revascularization often require inotropic support that has been associated with an increased risk for death and morbidity. The purpose of this study was to evaluate the effect of levosimendan versus control on survival after coronary revascularization.